Trials / Completed
CompletedNCT03491969
Clinical Study of Lipoic Acid on Ischemic Heart Failure
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the efficacy of alpha-lipoic acid(α-LA) on mortality in patients with ischemic heart failure (NYHA Class II - IV and EF =\< 50%).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alpha-Lipoic Acid(α-LA) | 200 mg, po, tid |
| DRUG | Placebos | 200 mg, po, tid |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2018-04-09
- Last updated
- 2025-07-14
- Results posted
- 2025-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03491969. Inclusion in this directory is not an endorsement.